Invention Grant
- Patent Title: Interference-suppressed immunoassay to detect anti-drug antibodies in serum samples
-
Application No.: US15078140Application Date: 2016-03-23
-
Publication No.: US10168326B2Publication Date: 2019-01-01
- Inventor: Kay-Gunnar Stubenrauch , Rudolf Vogel
- Applicant: Hoffmann-La Roche Inc.
- Applicant Address: US NJ Nutley
- Assignee: F. HOFFMANN-LA ROCHE INC.
- Current Assignee: F. HOFFMANN-LA ROCHE INC.
- Current Assignee Address: US NJ Nutley
- Agency: Foley & Lardner LLP
- Priority: EP13175091 20130704
- Main IPC: G01N33/53
- IPC: G01N33/53 ; G01N33/543 ; C07K16/28 ; G01N33/68

Abstract:
Herein is reported an enzyme linked immunosorbent assay for the detection of anti-drug antibodies against a drug antibody in a sample comprising a capture drug antibody and a tracer drug antibody, wherein the capture drug antibody and the tracer drug antibody are employed in a concentration of 0.5 μg/ml or more, the sample is incubated simultaneously with the capture drug antibody and the tracer drug antibody for 1 to 24 hours, the capture drug antibody and the tracer drug antibody are derivatized via a single lysine residue, the sample comprises 10% serum, and oligomeric human IgG is added to the sample prior to the incubation with the capture drug antibody and the tracer drug antibody.
Public/Granted literature
- US20160313322A1 INTERFERENCE-SUPPRESSED IMMUNOASSAY TO DETECT ANTI-DRUG ANTIBODIES IN SERUM SAMPLES Public/Granted day:2016-10-27
Information query
IPC分类: